Organigram Holdings is pleased to announce the relaunch of one of Canada’s best known cannabis brands, Trailblazer, exemplifying the company’s commitment to keeping consumer insights at the heart of its brand and product development strategy. More than a year in the making, Trailblazer’s modernized brand identity and revitalized product lineup represent a significant opportunity to connect with a large and important consumer segment whose needs were previously unmet by the Organigram brand portfolio. Featuring THCV gummies, CBG infused pre-rolls and a high-potency 1×0.5g pre-roll, Trailblazer will re-enter the market with a range of differentiated offerings.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OGI:
- Organigram to supply medical cannabis to 4C LABS, terms undisclosed
- Organigram price target lowered to C$4 from C$9 at Canaccord
- Organigram price target raised to C$4 from C$1.25 at Stifel
- Organigram price target lowered to C$4.00 from C$9.00 at Canaccord
- Organigram target adjusted to C$2.25 at Alliance Global after earnings, split